Skip to content

Clinical trials

Ocular Hypertension trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20121
20141
20162
20171
20181
20192
20201
20211
20221
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan4
Chong Kun Dang Pharmaceutical3
Kukje Pharma3
AbbVie1
CHA University1
Huons Co., Ltd.1
Inje University1
Kim's Eye Hospital1
Santen Pharmaceutical Asia Pte. Ltd.1
Taejoon Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension18
Glaucoma, Open-Angle14
Glaucoma5
Diabetic Retinopathy1
Eye Diseases1
Low Tension Glaucoma1
Macular Degeneration1
Retinal Vein Occlusion1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.